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Objective: To screen the cytotoxic effects of some marine sponges extracts on HeLa and
PC12 cells.
Methods: Five marine sponges including Ircinia echinata (I. echinata), Dysidea avara,
Axinella sinoxea, Haliclona tubifera and Haliclona violacea were collected from the
Persian Gulf (Hengam Island). The cytotoxic effect of these sponges was evaluated by
using MTT assay. The metabolic high performance liquid chromatography ﬁngerprint of
I. echinata was also carried out at two wavelengths (254 and 280 nm).
Results: Among the sponges tested in this study, the extracts of I. echinata and Dysidea
avara possessed the cytotoxic effect on HeLa and PC12 cells. The obtained fractions
from high performance liquid chromatography were evaluated for their cytotoxic prop-
erties against the cell lines. The isolated fractions did not show signiﬁcant cytotoxic
properties.
Conclusions: I. echinata could be considered as a potential extract for chemotherapy.
Further investigation is needed to determine the accuracy of mechanism.1. Introduction
Nowadays, cancer is a complex disease which is non-curable
in most cases [1]. Cervical cancer is one of the most common
cancers in Iran and the entire world. Current systemic
therapies for cancers are often limited by their non-speciﬁc ef-
fects and toxicity to normal tissues [2]. Although the main goal
of chemotherapy is elimination of tumor cells, in most cases,
chemotherapy inﬂuences normal cells and damages them [3].The main strategy of chemotherapy protocols is killing the
cancer cells without toxic effect on the host. Resistance of
cancer cells to conventional chemotherapeutic agents and
nonspeciﬁc effect of drugs for treatment of tumors are a com-
mon problem. This phenomenon leads to more aggressive
phenotype of the cells, which have a greater tendency to
metastasize. It also emphasizes the need to identify new anti-
cancer compounds; hence, it is necessary to investigate the
possible mechanisms of the synergistic effects between drugs
being commonly used.
Different natural compounds can improve the efﬁciency of
chemotherapeutic agents, decrease the resistance of cancer cells
to chemotherapeutic drugs and alleviate the adverse side effects
of chemotherapy [4]. Nowadays, researchers attempt to ﬁnd new
natural compounds with anticancer properties.
Sponges are sessile animals that ﬁlter water through their
porous bodies, ingest food particles and dissolve materials.an open access article under the CC BY-NC-ND
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99% of all sponges live in the marine environment. Sponges
also produce their own toxins through normal metabolism, or
in collaboration with many microbes that live inside them.
Whatever the source of these toxic chemicals is, many have
been found to be highly toxic to other life forms. In fact, some
of the most toxic chemicals known in nature have been
discovered from sponges. Researches indicated that one of the
toxic natural products was marine sponges. Because toxins
produced by marine sponges can immediately enter the sea, in
where they are diluted. As a result, the toxins produced by
these sponges must be very powerful in terms of effectiveness
that leads to toxicity. Some of these chemicals have potential
pharmaceutical applications, including anticancer, antimalaria
and analgesics [5]. In fact, the major reason why our
knowledge of sponges has escalated over the past few
decades is directly due to the increasing interest in their
pharmaceutical properties.
In this study, the cytotoxic effects of extracts and fractions
from marine sponges were evaluated on cervical cancer (HeLa)
and pheochromocytoma (PC12) cell lines.
2. Materials and methods
2.1. Reagents
MTT was purchased from Sigma. High-glucose Dulbecco's
Modiﬁed Eagles Medium, penicillin–streptomycin, fetal bovine
serum and 5× trypsin/ethylene diamine tetraacetic acid were
purchased from Gibco. HeLa and PC12 cells were obtained from
Pasteur Institute, Tehran, Iran. Paclitaxel manufactured by
EBWE Company was purchased from market.
2.2. Sponge material
The sponges [Ircinia echinata (I. echinata), Dysidea avara
(D. avara), Axinella sinoxea (A. sinoxea), Haliclona tubifera
(H. tubifera) and Haliclona violacea (H. violacea)] were
collected from the depths of 15–17, 10, 7–15, 15–20 and 15–
20 m in the Persian Gulf (Hengam Island), respectively, and
identiﬁed by Melika Nazemi.
2.3. Preparation of alcoholic extracts
The sponges were dried by freeze drier and powdered. About
50 g of powder was separated and extracted with methanol–
dichloromethane (1:1) at room temperature for 48 h. Then, the
solution was ﬁltered. This procedure was repeated three times
and the resulting extracts were combined. The combined extracts
were concentrated in vacuum and the residue was dried at 40 C
in incubator. This dried sample was stored at 4 C until use.
2.4. Cell culture
HeLa and PC12 cells were cultured as monolayers in 75 cm2
culture ﬂasks in high-glucose Dulbecco's Modiﬁed Eagles Me-
dium supplemented with 10% fetal bovine serum. The medium
was changed every 48 h and sub-cultured with 5× trypsin/
ethylene diamine tetraacetic acid. Cells were maintained at
37 C under a humidiﬁed atmosphere containing 5% CO2.2.5. Cell viability
Cytotoxicity was assessed using the colorimetric MTT assay.
Brieﬂy, the cells were seeded in 96 well tissue culture plates and
incubated with 50 mg/mL of each extract of sponges for 72 h.
Then in another 96 well tissue culture plates, the cells were
seeded and incubated with increasing concentrations of extract
of I. echinata (1, 10, 25 and 50 mg/mL) for 72 h. About 20 mL of
MTT in phosphate-buffered saline (5 mg/mL) was then added to
each well. Following 4 h incubation at 37 C, the medium/MTT
mixtures were removed and the blue insoluble formazan product
formed by living cells was dissolved in dimethyl sulfoxide
(DMSO) (100 mL/well). The optical density of the wells was
then measured with a microplate reader at 570 nm. All tests were
performed in triplicate and cytotoxicity was expressed as IC50,
which was calculated using GraphPad Prism 5 software and
presented as mean ± SEM of six independent experiments with
three replicates for each concentration. Paclitaxel was used as a
positive control.
2.6. Preliminary fractionations and metabolic
ﬁngerprinting using high performance liquid
chromatography (HPLC)–UV
2.6.1. Instruments
Chromatographic measurements were carried out using a
Knauer HPLC system (Berlin, Germany) equipped with a K-
1001 HPLC Pump and a UV detector K-2800 which was set at
254 and 280 nm. The other HPLC equipments included a
Knauer K-1500 solvent organizer and a Knauer K-500 degasser.
Adjustments of pH of solutions were determined by a 3030
Jenway pH meter (Leeds, UK). The column used was a C18
(250 mm × 21.2 mm, 5 mm) from Capital (Broxburn, UK). The
polyamide solid-phase extraction (SPE) cartridge (Chromabond
PA) (3 mL/500 mg) was obtained from Macherey–Nagel
(Du¨ren, Germany). The system was equipped with Chromgate
HPLC software, version 3.3.
2.6.2. Sample preparation and SPE
Sponges were directly collected from Persian Gulf without
any commercial manipulation in order to avoid potential
changes during handling, storage and processing. The SPE
polyamide cartridge was sequentially conditioned with 5 mL of
n-hexane, 5 mL of methanol and 10 mL of double distilled
deionized water without allowing the cartridge to be dried. The
ﬁltrate was passed through the cartridge, washed by 8 mL water/
methanol (80:20 v/v, adjusted at pH = 3 with concentrated HCl)
to remove interferences and eluted with 4 mL HPLC grade
methanol. The elution was dried by blowing N2 stream and
dissolved in 1 mL of acetonitrile, ﬁltered through a 0.45 mm
syringe ﬁlter and injected into the HPLC system.
2.6.3. Chromatographic conditions
Fractionation of I. echinata extract was performed using
reversed-phase HPLC with a linear gradient mobile phase of
20%–100% methyl alcohol in H2O including 0.05% triﬂuoro-
acetic acid with a ﬂow rate of 9 mL/min at room temperature.
About 300 mg of I. echinata was dissolved in 2 mL DMSO. The
sample was loaded on an ACE 5 C18 column (5 mmol/L,
250 mm × 21.2 mm) (Advanced Chromatography Technologies
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and analyses were monitored at 254 and 280 nm. To validate the
gradient method, a standard sample containing uracil, methyl p-
hydroxybenzoate, ethyl p-hydroxybenzoate and benzophenone
was injected repeatedly until four thoroughly separated peaks
were observed. To separate the fractions, we injected 1 mL of
the prepared extract of I. echinata into the HPLC.
2.7. Statistical analysis
All the data were analyzed using One-way ANOVA followed
by Tukey–Kramer's multiple comparison test. P values < 0.05
were considered signiﬁcant.
3. Results
3.1. Effect of marine sponges extracts on cell viability in
HeLa
As shown in Figure 1, I. echinata incubated at 50 mg/mL
signiﬁcantly decreased cell viability to 47% of control
(P < 0.001), and D. avara at 50 mg/mL signiﬁcantly decreasedFigure 1. Effect of alcoholic extracts of marine sponges on cell viability in
HeLa cells.
Cells were incubated with 50 mg/mL sponge extract for 72 h. Viabilities
were determined by MTT assay. Results were expressed as mean ± SEM of
six independent experiments. IE: I. echinata; DA: D. avara; AS:
A. sinoxea; HT: H. tubifera; HV: H. violacea; *: P < 0.05; ***: P < 0.001
compared to control.
Figure 2. Effect of alcoholic extracts of marine sponges on cell viability in
PC12 cells.
Cells were incubated with 50 mg/mL sponges extracts for 72 h. Viabilities
were determined by MTT assay. Results were expressed as mean ± SEM of
six independent experiments. *: P < 0.05; **: P < 0.01; ***: P < 0.001
compared to control.cell viability to 76.64% of control (P < 0.05). However, the
other extracts of sponges were not able to reduce cell growth
signiﬁcantly as compared with negative control including cancer
cells and medium without drug. Paclitaxel as positive control
showed the viability of 3.7% at a concentration of 0.6 mg/mL
(P < 0.001).
3.2. Effect of marine sponges extracts on cell viability in
PC12
As shown in Figure 2, I. echinata incubated at 50 mg/mL
signiﬁcantly decreased cell viability to 68% of control
(P < 0.01), and D. avara signiﬁcantly decreased cell viability to
79.03% of control (P < 0.05). However, the other extracts of
sponges were not able to reduce cell viabilities signiﬁcantly.
Paclitaxel as positive control reduced the viability to 4.5% at a
concentration of 0.6 mg/mL (P < 0.001).
3.3. Effect of I. echinata extract on cell viability in HeLa
and PC12 cells
As shown in Figure 3, I. echinata signiﬁcantly decreased cell
viability to 47% (P < 0.001) and 68% (P < 0.01) in HeLa and
PC12, respectively at 50 mg/mL, but the other concentrations did
not show signiﬁcant effect. Among the tested sponges,
I. echinata showed the highest activity against HeLa and PC12,
so it was further fractionated.
3.4. Fractionation of I. echinata extract using HPLC
It had experimentally been revealed that compounds with
retention times between those of 4-hydroxymethyl benzoate
and benzophenone have suitable physicochemical properties to
be absorbed through gastrointestinal tract and are orally
bioavailable. Peaks of compounds from marine extracts that
appeared in the ﬁrst 8 min in HPLC chromatograms were not
typically evaluated due to high quantities of marine salts
(Figures 4 and 5).
To separate the fractions, we injected 1 mL of the prepared
extract of I. echinata into the HPLC and the fractions 1 and 2
were isolated according to chromatogram in the wavelength of
254 nm.Figure 3. Effect of increasing doses of alcoholic extract of I. echinata on
cell viability in HeLa and PC12 cells.
Cells were incubated with 1, 10, 25 and 50 mg/mL of I. echinata extract for
72 h. Viabilities were tested using MTT assay. Results were expressed as
mean ± SEM of six independent experiments. **: P < 0.01; ***: P < 0.001
compared to control.
Figure 4. The HPLC ﬁngerprint analysis of I. echinata extract at 254 nm for 30 min run time.
Figure 5. The HPLC ﬁngerprint analysis of I. echinata extract at 280 nm for 30 min run time.
Figure 6. Effect of fractions of alcoholic extract of I. echinata on cell viability of HeLa and PC12 cells.
F1: Fraction 1; F2: Fraction 2. Cells were incubated with 1, 10, 25 and 50 mg/mL extract of sponge for 72 h. Viabilities were tested using MTT assay. Results
were expressed as mean ± SEM of six independent experiments.
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viability in HeLa and PC12 cells
As shown in Figure 6, fractions from I. echinata extract
exhibited no effect at different concentrations on HeLa and
PC12 cells proliferation.
4. Discussion
Cancer is a growing health problem in both developing and
developed countries. According to the recent report of World
Health Organization [6], 8.2 million patients died from cancer in
2012. It has been also estimated that the number of annual
cancer cases will have been increased from 14 million in 2012
to 22 million within the next two decades [6]. Cervical cancer
is the second most common cancer in Iran. Unfortunately, this
type of cancer is developing rapidly [6]. Currently, the main
treatments for cancer are chemotherapy, radiotherapy and
surgery. Some of the most used chemotherapy drugs include
antimetabolites (e.g. methotrexate), DNA-interactive agents
(e.g. cisplatin, doxorubicin), antitubulin agents (taxanes), hor-
mones and molecular targeting agencisplatints [7]. However,
clinical uses of these drugs are accompanied by several
unwanted effects such as hair loss, suppression of bone
marrow, drug resistance, gastrointestinal lesions, neurologic
dysfunction and cardiac toxicity [7–9]. Therefore, the search for
new anticancer agents with better efﬁcacy and less side effects
has been continued.
Natural compounds are good sources for the development of
new remedies for different diseases. These compounds have
been applied for treating and preventing human disease such as
infection, cancer, pain and immune disease.
The ocean occupies about 70% of the earth and contains a huge
number of marine organisms. Although collecting and identifying
marine organisms were difﬁcult to researchers, but marine re-
sources are still attractive for pharmaceutical industries. Among
marine resources, marine sponges are known to have about 15000
species worldwide. This study describes a screening for cyto-
toxicity of extracts of ﬁve marine sponges collected from Persian
Gulf. Our ﬁndings revealed that among the extracts of ﬁve
sponges, the extracts of I. echinata and D. avara inhibited cell
growth at dose of 50 mg/mL with different potency. In our study,
we separated fractions on the basis of quadruple standard
including uracil, 4-hydroxymethyl benzoate, 4-hydroxy ethyl
benzoate and benzophenone. According to the retention times of
these compounds, we were able to identify and isolate compounds
with drug-like properties and avoid isolating very polar com-
pounds including salts that are commonly present in marine ex-
tracts. Taken together, the isolated fractions did not show
signiﬁcant cytotoxic properties. But it should be investigated
whether fractions from HPLC columns in the ﬁrst 8 min might
contain cytotoxic compounds. One may suppose that cell growth
can be affected by change in osmolality due to high amount of
salts in total extracts. It should be pointed out, however, the low
concentration 50 mg/mL of total extract that we used in cytotox-
icity assay is not able to affect osmolarity of cell culture. Therefore
we expect that cytotoxic effects observed for I. echinata could be
due to its cytotoxic compounds.
Recent years, marine organisms have been recognized as a
resource for novel bioactive compounds. Marines have been used
formedicinal purposes in India, China and theNear East.Marine is
composed of biomolecules such as peptides, enzymes, enzymeinhibitors and lipids which have the potential for the prevention
and treatment of cancer. Puriﬁed peptides from this source have
been shown to have cytotoxic effects on several human cancers
such as pancreatic, breast, bladder and lung cancers. Different
studies have reported cytotoxicity effects of sponges on cell lines.
Hyrtios spp. increased cell death in colorectal carcinomaRKO cell
line by the induction of p53 and p21 proteins [10]. In another study,
themarine spongeAurora globostellata exhibited strong cytotoxic
activities against a panel of cancer cells [11]. The anticancer
properties of marine sponges might be due to the presence of the
active secondary metabolites such as alkaloids and quinine
derivatives [12]. Alkaloids are microtubule intermediary agents
which can bind with beta-tubulin, thus preventing the cell from
making the mitotic spindle ﬁbers which is necessary to move the
chromosome around when the cell divides [13], inhibiting
topoisomerase [14], mitochondrial damage and inducing the
release of cytochrome C and apoptosis inducing factors.
Moreover, quinine derivatives can interfere the DNA and RNA
replication and mitochondrial oxidative pathways or the
formation of super oxide, peroxide and hydroxide radicals as
toxic products in the cell line [11]. Triterpenoids are the most
abundant secondary metabolite present in marine sponges. A
large number of triterpenoids are known to exhibit cytotoxicity
against a variety of tumor cells as well as anticancer efﬁcacy in
preclinical animal models [15].
Ultimately, further investigation is needed to determine the
mechanism of action for cytotoxic activity of I. echinata as well
as characterization of active compounds in its extract.
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